The oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and organ damage and reduce life expectancy.
Save my name, email, and website in this browser for the next time I comment.
Your Name (required)
Your Email (required)
Subject
Your Message
WhatsApp us
